These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16128950)

  • 1. Elevated circulating platelet-derived microparticles in patients with active inflammatory bowel disease.
    Andoh A; Tsujikawa T; Hata K; Araki Y; Kitoh K; Sasaki M; Yoshida T; Fujiyama Y
    Am J Gastroenterol; 2005 Sep; 100(9):2042-8. PubMed ID: 16128950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated thrombopoietin serum levels in patients with inflammatory bowel disease.
    Kapsoritakis AN; Potamianos SP; Sfiridaki AI; Koukourakis MI; Koutroubakis IE; Roussomoustakaki MI; Manousos ON; Kouroumalis EA
    Am J Gastroenterol; 2000 Dec; 95(12):3478-81. PubMed ID: 11151880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating soluble interleukin-2 receptor alpha and beta chain in inflammatory bowel disease.
    Nielsen OH; Ciardelli T; Wu Z; Langholz E; Kirman I
    Am J Gastroenterol; 1995 Aug; 90(8):1301-6. PubMed ID: 7639234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The circulating common gamma chain (CD132) in inflammatory bowel disease.
    Nielsen OH; Kirman I; Johnson K; Giedlin M; Ciardelli T
    Am J Gastroenterol; 1998 Mar; 93(3):323-8. PubMed ID: 9517632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 levels in inflammatory bowel disease.
    Koutroubakis IE; Sfiridaki A; Tsiolakidou G; Coucoutsi C; Theodoropoulou A; Kouroumalis EA
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):912-6. PubMed ID: 18794606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of soluble angiopoietin-2 and Tie-2 in patients with inflammatory bowel disease.
    Koutroubakis IE; Xidakis C; Karmiris K; Sfiridaki A; Kandidaki E; Kouroumalis EA
    Eur J Clin Invest; 2006 Feb; 36(2):127-32. PubMed ID: 16436095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells.
    Baumgart DC; Metzke D; Schmitz J; Scheffold A; Sturm A; Wiedenmann B; Dignass AU
    Gut; 2005 Feb; 54(2):228-36. PubMed ID: 15647187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of platelet-derived microparticle levels in the chronic phase of cerebral infarction using an enzyme-linked immunosorbent assay.
    Shirafuji T; Hamaguchi H; Kanda F
    Kobe J Med Sci; 2008 May; 54(1):E55-61. PubMed ID: 18772609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease.
    Valentini L; Wirth EK; Schweizer U; Hengstermann S; Schaper L; Koernicke T; Dietz E; Norman K; Buning C; Winklhofer-Roob BM; Lochs H; Ockenga J
    Nutrition; 2009 Feb; 25(2):172-81. PubMed ID: 18849144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombopoietin serum levels in patients with inflammatory bowel disease with and without previous thromboembolic events.
    Papa A; Danese S; Piccirillo N; Toriani-Terenzi C; Bartolozzi F; Piscaglia AC; Grillo A; Leone G; Gentiloni-Silveri N; Gasbarrini G; Gasbarrini A
    Hepatogastroenterology; 2003; 50(49):132-5. PubMed ID: 12630008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of soluble CD40 ligand are elevated in inflammatory bowel diseases.
    Ludwiczek O; Kaser A; Tilg H
    Int J Colorectal Dis; 2003 Mar; 18(2):142-7. PubMed ID: 12548417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The insulin-like growth factor (IGF)-system in active ulcerative colitis and Crohn's disease: relations to disease activity and corticosteroid treatment.
    Eivindson M; Grønbaek H; Flyvbjerg A; Frystyk J; Zimmermann-Nielsen E; Dahlerup JF
    Growth Horm IGF Res; 2007 Feb; 17(1):33-40. PubMed ID: 17126585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased circulating platelet-neutrophil, platelet-monocyte complexes, and platelet activation in patients with ulcerative colitis: a comparative study.
    Pamuk GE; Vural O; Turgut B; Demir M; Umit H; Tezel A
    Am J Hematol; 2006 Oct; 81(10):753-9. PubMed ID: 16941615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High plasma osteopontin levels in patients with inflammatory bowel disease.
    Mishima R; Takeshima F; Sawai T; Ohba K; Ohnita K; Isomoto H; Omagari K; Mizuta Y; Ozono Y; Kohno S
    J Clin Gastroenterol; 2007 Feb; 41(2):167-72. PubMed ID: 17245215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum angiotensin I-converting enzyme is reduced in Crohn's disease and ulcerative colitis irrespective of genotype.
    Matsuda T; Suzuki J; Furuya K; Masutani M; Kawakami Y
    Am J Gastroenterol; 2001 Sep; 96(9):2705-10. PubMed ID: 11569699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of prothrombin activation fragments in young patients with inflammatory bowel disease.
    Smith CJ; Haire WD; Kaufman SS; Mack DR
    Am J Gastroenterol; 1996 Jun; 91(6):1221-5. PubMed ID: 8651175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of platelet-derived microparticle levels using an enzyme-linked immunosorbent assay in polymyositis and dermatomyositis patients.
    Shirafuji T; Hamaguchi H; Higuchi M; Kanda F
    Muscle Nerve; 2009 May; 39(5):586-90. PubMed ID: 19347930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistin is an inflammatory marker of inflammatory bowel disease in humans.
    Konrad A; Lehrke M; Schachinger V; Seibold F; Stark R; Ochsenkühn T; Parhofer KG; Göke B; Broedl UC
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1070-4. PubMed ID: 17998831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating L-selectin levels and endothelial CD34 expression in inflammatory bowel disease.
    Seidelin JB; Vainer B; Horn T; Nielsen OH
    Am J Gastroenterol; 1998 Oct; 93(10):1854-9. PubMed ID: 9772044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.